Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
about
Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesisPhysical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-YT helper cell activation and human retroviral pathogenesisSilencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanismsTranscriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 ProvirusRoles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related DiseasesHow does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?Modes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and PersistenceTreatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted TherapyMolecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic diseaseRegulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex.Serological identification of adult T-cell leukaemia-associated antigens.Expression of human T-cell lymphotropic virus type-1 gene products in the short-term cultured skin tissues of an adult T-cell leukemia/lymphoma patient with cutaneous manifestations.Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.Pathogenesis and treatment of HTLV-I associated myelopathy.Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.HLA class I binding of HBZ determines outcome in HTLV-1 infection.A comparative study of experimental mouse models of central nervous system demyelination.Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult rats.Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockadeLymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responsesInteractions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system.Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.Induction of adult T-cell leukemia-like lymphoproliferative disease and its inhibition by adoptive immunotherapy in T-cell-deficient nude rats inoculated with syngeneic human T-cell leukemia virus type 1-immortalized cells.Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax.Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathyIdentification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantationIL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients.Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity.Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis.Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression
P2860
Q21131133-281E6F54-0E5A-411C-81D4-059F0DA1B25CQ24647157-ACF8E152-2B52-4827-AF50-2E47EC90B28FQ24650854-F5C2F422-CE05-48D8-8D6F-E5EB19E88C7DQ24811510-3D1CCD88-739A-429C-9CFF-BF88B3BB5C1BQ26744327-986620C8-1EF6-477B-B440-C41AE77C9DE9Q26774352-B0F8E562-7ABB-439F-9804-BC76AEE1A834Q26785554-AD466DCC-29FF-48C9-BFA0-54F23AB4E884Q26801294-053B5024-46FE-4292-8C3A-052CE1449406Q28972318-69D1EF7D-7F79-4A87-9FA7-F85244861728Q30698124-D0AD2167-A58D-4621-AC26-92B77B40D55FQ30973354-87E47AB6-01B8-4AA6-99BA-3622E0D4C3BFQ31156885-BF655B9D-D39A-4942-B517-8D96A479B04EQ33220307-70DAC7BB-2891-4CC2-A65B-A3C1B179CE93Q33231124-FB28E082-4BAD-450F-8766-5C8CF813A0A2Q33490596-50400BF6-48C4-44C0-906B-65A62EA1D571Q33589322-6ECBD35D-E05C-4DC2-973B-29CA09F56F21Q33637013-AC718BDB-28ED-498F-B332-7D4F2C2BF65DQ33651831-DDAFAD3F-5682-4D37-A2EF-E78EE82CCB0CQ33652150-B5426AC1-A350-445A-B230-29F48E03D9C2Q33655605-F1086E2E-820F-46E2-A737-E8B6B4E00147Q33707746-3EB6BAB7-EB80-4F96-B5D5-E16130C1FAC2Q33717475-A4954E3A-17FA-41EB-A9C3-5D76354041ADQ33768325-71547F94-0016-4341-953F-6D94FE7D0C2BQ33779820-E197A920-BC76-408D-B0E0-CCA1F38056EDQ33783833-0245EEA6-DA94-4529-8107-6626B09E1907Q33795171-1CD8E4B8-C10C-459C-BDE8-AD3014F74711Q33805038-C082872B-3129-46F0-B9CB-D8AEA9835D1FQ33806783-F6CDA1A0-200D-4FCA-A0B4-9ADE2609839CQ33811681-32A2B358-B4A2-4376-A3F1-2C04E3F7254DQ33815891-02E311F7-6A57-4FD6-813B-86B4142FAD78Q33816840-ACA2A4E0-DD76-42BB-82C4-2A467EB0DA0EQ33825371-C53AF908-C70D-4F1F-B9EA-8196BD76F3A2Q33908704-D8807DC0-10F9-4923-9CC9-6408DA497367Q33952031-3B5992A8-1661-4B27-848B-B13DEC1A77B3Q33956264-C8F20BAB-1C0A-4363-AABA-AE6835346C68Q34156338-7A4E9DB3-4021-48E9-AA54-6D12088F70BEQ34157297-070BDFE5-D1EA-4AAE-A9C1-0C03A637BE08Q34157538-F0EA75DC-E059-40E5-AAE6-1F3CC55F03D9Q34258809-8EA5A982-3564-4E6F-B951-E3C266B5EF9FQ34332433-8EB62B6E-58BA-456F-AD90-DF7DD7368FAE
P2860
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Circulating CD8+ cytotoxic T l ...... sociated neurological disease.
@en
Circulating CD8+ cytotoxic T l ...... sociated neurological disease.
@nl
type
label
Circulating CD8+ cytotoxic T l ...... sociated neurological disease.
@en
Circulating CD8+ cytotoxic T l ...... sociated neurological disease.
@nl
prefLabel
Circulating CD8+ cytotoxic T l ...... sociated neurological disease.
@en
Circulating CD8+ cytotoxic T l ...... sociated neurological disease.
@nl
P2093
P356
P1433
P1476
Circulating CD8+ cytotoxic T l ...... sociated neurological disease.
@en
P2093
P2888
P304
P356
10.1038/348245A0
P407
P577
1990-11-01T00:00:00Z
P6179
1008029181